
Pomerantz Law Firm Warns Neumora Therapeutics Investors: Class Action Lawsuit Filed, Upcoming Deadlines Approach
Class Action Lawsuit Filed Against Neumora Therapeutics: What Does This Mean for Investors and the World? In a recent development, Pomerantz LLP, a renowned securities litigation firm, announced the filing of a class action lawsuit against Neumora Therapeutics, Inc. (Neumora or the Company) on March 17, 2025. Neumora is a biopharmaceutical company specializing in the…